Provider QP49-21 Update for New to Market Medical Drugs: Anifrolumab, Teplizumab, Donislecel, and Difelikefalin Read More
Provider QP48-21 Learn to Live – An Online Behavioral Health Resource for Select Blue Cross and Blue Shield of Minnesota Health Plan Members Read More
Provider QP50-21 Commercial Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective August 1, 2021 Read More
Provider QP51-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective July 25, 2021 Read More
Provider QP47-21 Audio-Only Telehealth Visits do not Meet Requirements for Risk Adjustment Face-to-Face Requirement Read More
